MAB1304
Mouse Anti-Human IgG Antibody, Fd, clone HP6045
clone HP6045, Chemicon®, from mouse
Sign Into View Organizational & Contract Pricing
All Photos(1)
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.46
Recommended Products
biological source
mouse
Quality Level
antibody form
purified immunoglobulin
antibody product type
secondary antibodies
clone
HP6045, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
radioimmunoassay: suitable
western blot: suitable
isotype
IgG1
shipped in
wet ice
target post-translational modification
unmodified
Related Categories
Specificity
Human IgG Fd.
ELISA Specificity: (Hamilton et al., 1987)
human IgG subclass 1 100%
human IgG subclass 2 100%
human IgG subclass 3 100%
human IgG subclass 4 99%
human IgG Pan 100%
human IgG Fc 0.04%
human IgG Fab 100%
Isoelectric Focusing: mean pI 6.5
ELISA Specificity: (Hamilton et al., 1987)
human IgG subclass 1 100%
human IgG subclass 2 100%
human IgG subclass 3 100%
human IgG subclass 4 99%
human IgG Pan 100%
human IgG Fc 0.04%
human IgG Fab 100%
Isoelectric Focusing: mean pI 6.5
Immunogen
Epitope: Fd region
Application
Research Category
Secondary & Control Antibodies
Secondary & Control Antibodies
Research Sub Category
Fragment Specific Secondary Antibodies
Fragment Specific Secondary Antibodies
This Mouse anti-Human IgG Antibody, Fd, clone HP6045 is validated for use in ELISA, RIA, WB for the detection of Human IgG.
Useful as both a capture antibody and a detection antibody for human IgG Fd (Papadea, C., et al., Clin. Chem. (1985). 31(12):1940-1945; Hamilton, R.G., et al., Electrophoresis (1987) 8:127-134).
ELISA
Radioimmunoassay (RIA)
Western blotting.
Final working dilutions must be determined by end user.
ELISA
Radioimmunoassay (RIA)
Western blotting.
Final working dilutions must be determined by end user.
Physical form
Format: Purified
Liquid in 0.02 M phosphate buffer with 0.25 M NaCl and 0.1% sodium azide.
Storage and Stability
Maintain at 2-8°C in undiluted aliquots for up to six months after date of receipt.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Shohei Ogata et al.
PloS one, 8(12), e81448-e81448 (2013-12-11)
Although intravenous immunoglobulin (IVIG) is highly effective in Kawasaki disease (KD), mechanisms are not understood and 10-20% of patients are treatment-resistant, manifesting a higher rate of coronary artery aneurysms. Murine models suggest that α2-6-linked sialic acid (α2-6Sia) content of IVIG
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service